Forefront Analytics, LLC

SEC CIK: 0001696802
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

THRX holding history

Theseus Pharmaceuticals, Inc. in every 13F filed by Forefront Analytics, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

THRX overview All 13F holders of THRX Full Q2 2026 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2022

Holdings of THRX by Forefront Analytics, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−17,672−100.0%	Sold out	Holders
Q3 2023	17,672	$47.5K	<0.1%	+17,672	New	Holders
Q4 2022	0	$0	0.0%	−13,065−100.0%	Sold out	Holders
Q3 2022	13,065	$74.0K	<0.1%	+13,065	New	Holders